Ratios Uncovered: Breaking Down Cohen & Steers Inc (CNS)’s Trailing Twelve Months Metrics

Nora Barnes

The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.

The price of Cohen & Steers Inc (NYSE: CNS) closed at $65.91 in the last session, down -4.17% from day before closing price of $68.78. In other words, the price has decreased by -$4.17 from its previous closing price. On the day, 0.58 million shares were traded. CNS stock price reached its highest trading level at $68.935 during the session, while it also had its lowest trading level at $64.84.

Ratios:

We take a closer look at CNS’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 8.34 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 15.09. For the most recent quarter (mrq), Quick Ratio is recorded 4.61 and its Current Ratio is at 4.61. In the meantime, Its Debt-to-Equity ratio is 0.25 whereas as Long-Term Debt/Eq ratio is at 0.25.

Upgrades & Downgrades

In the most recent recommendation for this company, BofA Securities on June 30, 2025, initiated with a Underperform rating and assigned the stock a target price of $67.

On October 17, 2024, UBS Upgraded its rating to Neutral which previously was Sell and also upped its target price recommendation from $63 to $102.

On January 05, 2024, UBS started tracking the stock assigning a Sell rating and target price of $68.UBS initiated its Sell rating on January 05, 2024, with a $68 target price.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 19 ’25 when STEERS ROBERT HAMILTON bought 25,000 shares for $59.88 per share. The transaction valued at 1,496,880 led to the insider holds 7,147,497 shares of the business.

COHEN MARTIN bought 50,000 shares of CNS for $2,984,500 on Nov 18 ’25. The Director now owns 899,205 shares after completing the transaction at $59.69 per share. On Nov 19 ’25, another insider, COHEN MARTIN, who serves as the Director of the company, bought 37,292 shares for $59.66 each. As a result, the insider paid 2,224,884 and bolstered with 936,497 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CNS now has a Market Capitalization of 3361907200 and an Enterprise Value of 3235473152. As of this moment, Cohen’s Price-to-Earnings (P/E) ratio for their current fiscal year is 22.13, and their Forward P/E ratio for the next fiscal year is 17.48. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.05 while its Price-to-Book (P/B) ratio in mrq is 6.11. Its current Enterprise Value per Revenue stands at 5.818 whereas that against EBITDA is 17.094.

Stock Price History:

The Beta on a monthly basis for CNS is 1.25, which has changed by -0.26791072 over the last 52 weeks, in comparison to a change of 0.15024745 over the same period for the S&P500. Over the past 52 weeks, CNS has reached a high of $91.07, while it has fallen to a 52-week low of $58.39. The 50-Day Moving Average of the stock is 2.80%, while the 200-Day Moving Average is calculated to be -7.46%.

Shares Statistics:

According to the various share statistics, CNS traded on average about 409.04K shares per day over the past 3-months and 403240 shares per day over the past 10 days. A total of 51.01M shares are outstanding, with a floating share count of 27.24M. Insiders hold about 46.61% of the company’s shares, while institutions hold 55.85% stake in the company. Shares short for CNS as of 1767139200 were 1670898 with a Short Ratio of 4.08, compared to 1764288000 on 1761392. Therefore, it implies a Short% of Shares Outstanding of 1670898 and a Short% of Float of 5.9799999999999995.

Dividends & Splits

The forward annual dividend rate for CNS is 2.48, which was 2.48 in the trailing 12 months. Against a Trailing Annual Dividend Yield of 0.036056995. The stock’s 5-year Average Dividend Yield is 2.94.

Earnings Estimates

Its stock is currently analyzed by 1.0 different market analysts. The consensus estimate for the next quarter is $0.82, with high estimates of $0.82 and low estimates of $0.82.

Analysts are recommending an EPS of between $3.41 and $3.33 for the fiscal current year, implying an average EPS of $3.37. EPS for the following year is $3.65, with 2.0 analysts recommending between $3.77 and $3.54.

Revenue Estimates

According to 2 analysts,. The current quarter’s revenue is expected to be $143.62M. It ranges from a high estimate of $145.89M to a low estimate of $141.35M. The current estimate, Cohen & Steers Inc’s year-ago sales were $134.47MFor the next quarter, 2 analysts are estimating revenue of $148.1M. There is a high estimate of $149.49M for the next quarter, whereas the lowest estimate is $146.71M.

A total of 1 analysts have provided revenue estimates for CNS’s current fiscal year. The highest revenue estimate was $602.15M, while the lowest revenue estimate was $602.15M, resulting in an average revenue estimate of $602.15M. In the same quarter a year ago, actual revenue was $556.12MBased on 1 analysts’ estimates, the company’s revenue will be $642.81M in the next fiscal year. The high estimate is $642.81M and the low estimate is $642.81M.

DwinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.